Myrefen
Brand Name: Myrefen
Generic Name: Mefenamic Acid
Active
Registration Number
DRP-244
Dosage Form
Suspension
Issuance Date
January 31, 2023
Expiry Date
January 31, 2028
Product Information
Philippine FDA product specifications and classification details
Product Specifications
Dosage Strength50mg/5mL
PackagingAmber Glass Bottle x 60mL (Box of 1's)
Classification
C
Classification
Prescription Drug (RX)
P
Pharmacologic
Anti-Inflammatory /Antirheumatic (Fenamates)
A
Application
Initial (Variation)
Philippine FDA Classification
Active Ingredients (1)
Complete list of active ingredients in this pharmaceutical product.
Mefenamic AcidActive
Monograph: Mefenamic acid